Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction

BACKGROUND: The liver effect of orlistat as a weight control treatment in patients with nonalcoholic fatty liver disease (NAFLD) with obesity remains undetermined. This study quantified liver fat improvement by orlistat in a Chinese cohort with NAFLD accompanied by obesity, diagnosed by a lower body...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Therap Adv Gastroenterol
Asıl Yazarlar: Ye, Junzhao, Wu, Yanqin, Li, Fuxi, Wu, Tingfeng, Shao, Congxiang, Lin, Yansong, Wang, Wei, Feng, Shiting, Zhong, Bihui
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767749/
https://ncbi.nlm.nih.gov/pubmed/31632457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819879047
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller